Chemfab Alkalis Ltd Falls to 52-Week Low of Rs 270 as Sell-Off Deepens

2 hours ago
share
Share Via
A sharp decline has pushed Chemfab Alkalis Ltd to a fresh 52-week low of Rs 270 on 1 Apr 2026, marking a significant 70% drop from its 52-week high of Rs 900. This fall comes despite a brief intraday recovery, underscoring persistent selling pressure on the stock.
Chemfab Alkalis Ltd Falls to 52-Week Low of Rs 270 as Sell-Off Deepens

Price Action and Market Context

After opening with a gap down of 8.33%, Chemfab Alkalis Ltd managed to touch an intraday high of Rs 320, gaining 8.64% from the low, but ultimately closed near its low point. This followed two consecutive days of losses, signalling a continuation of the downward trend. Notably, the stock outperformed its sector by 6.63% today, suggesting some selective buying interest despite the overall weakness. However, the stock remains below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating a sustained bearish technical setup. What is driving such persistent weakness in Chemfab Alkalis Ltd when the broader market is in rally mode?

The broader market paints a contrasting picture. The Sensex opened 1,814.88 points higher and is currently trading at 73,857.01, up 2.65%. Despite this rally, the Sensex remains 3.29% above its 52-week low and is trading below its 50-day moving average, with the 50 DMA itself below the 200 DMA, signalling a cautious market environment. Mega-cap stocks are leading the gains, while micro-cap names like Chemfab Alkalis Ltd continue to lag behind.

Financial Performance and Profitability Concerns

The financials of Chemfab Alkalis Ltd reveal a challenging operating environment. The company has reported negative results for 11 consecutive quarters, with the latest quarter showing net sales of Rs 68.14 crores, down 20.8% compared to the previous four-quarter average. Operating profit to interest coverage has deteriorated to a low of 0.96 times, signalling tight financial cushioning against interest obligations. The net profit after tax (PAT) plunged by 670.5% relative to the previous four-quarter average, registering a loss of Rs 4.45 crores.

These figures highlight a widening gap between the income statement and the share price, with profitability metrics deteriorating sharply even as the stock price has collapsed. The company’s return on capital employed (ROCE) stands at a modest 1.8%, reflecting limited efficiency in generating returns from its capital base. Does the sell-off in Chemfab Alkalis Ltd represent an overreaction to temporary headwinds, or is the market pricing in something deeper?

Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?

  • - Building momentum strength
  • - Investor interest growing
  • - Limited time advantage

Join the Momentum →

Valuation and Long-Term Growth Trends

Valuation metrics for Chemfab Alkalis Ltd present a complex picture. The stock trades at a discount relative to its peers’ historical averages, yet this is tempered by the company’s weak fundamentals. The enterprise value to capital employed ratio is 1.1, which is relatively expensive given the company’s low ROCE of 1.8%. This suggests that the market is cautious about the company’s ability to generate sustainable returns.

Long-term growth has been disappointing, with operating profit shrinking at an annualised rate of 28.88% over the past five years. The stock’s one-year performance has been particularly poor, delivering a negative return of 57.86%, compared to the Sensex’s modest decline of 2.95% over the same period. This underperformance extends to the three-year and three-month horizons as well, where the stock has lagged the broader BSE500 index.

Despite the valuation discount, the company’s financial trajectory and profitability challenges weigh heavily on investor sentiment. With the stock at its weakest in 52 weeks, should you be buying the dip on Chemfab Alkalis Ltd or does the data suggest staying on the sidelines?

Technical Indicators and Market Sentiment

The technical outlook for Chemfab Alkalis Ltd remains predominantly bearish. Weekly and monthly MACD and Bollinger Bands indicators signal downward momentum, while the daily moving averages confirm the stock is trading below all key levels. The KST indicator shows mild bullishness on a weekly basis but remains bearish monthly, reflecting short-term attempts at recovery amid longer-term weakness. Dow Theory assessments are mildly bearish across weekly and monthly timeframes, and the On-Balance Volume (OBV) indicator shows no clear trend weekly but a bullish signal monthly, suggesting some accumulation interest over a longer horizon.

These mixed signals indicate that while the stock is under pressure, there may be pockets of buying interest. However, the overall technical configuration points to continued challenges ahead. Is this a recovery or a dead-cat bounce in the technical landscape for Chemfab Alkalis Ltd?

Balance Sheet and Shareholding Structure

On the balance sheet front, Chemfab Alkalis Ltd maintains a low average debt-to-equity ratio of 0.10 times, which is a positive aspect in terms of financial leverage. The company’s capital structure is predominantly promoter-owned, with majority shareholders being promoters, indicating concentrated ownership. This ownership pattern may provide some stability in shareholding, even as the stock price declines.

Why settle for Chemfab Alkalis Ltd? SwitchER evaluates this Commodity Chemicals micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Summary and Investor Considerations

The trajectory of Chemfab Alkalis Ltd over the past year has been marked by a steep decline in share price alongside deteriorating profitability and subdued growth metrics. The stock’s fall to Rs 270 represents a 70% drop from its peak, reflecting the market’s concerns about the company’s earnings outlook and operational performance. While the company’s low leverage and promoter ownership provide some balance sheet comfort, the persistent losses and weak operating metrics continue to weigh on sentiment.

Investors face a complex picture where valuation discounts coexist with fundamental challenges and bearish technical signals. Buy, sell, or hold at a 52-week low? The complete multi-factor analysis of Chemfab Alkalis Ltd weighs all these signals.

Key Data at a Glance

52-Week Low
Rs 270
52-Week High
Rs 900
1-Year Return
-57.86%
Sensex 1-Year Return
-2.95%
Latest Quarterly Sales
Rs 68.14 crores (-20.8%)
Latest Quarterly PAT
Rs -4.45 crores (-670.5%)
Operating Profit Growth (5Y)
-28.88% CAGR
Debt to Equity (Avg)
0.10 times
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News